CHA Medical Group the Global Leader of Modern Medical Science and 50 years of historical CHA HEALTH SYSTEM in Korea. World Leading Technology in Stem Cell of CHA Medical Group. By using Stem Cell technology, the core field of future medical science of 21st century, treatment of incurable disease, total studies of embryo-fetus and adult stem cell, endless development of related original technology, passions and incredible outcomes could CHA Stem Cell Institute build up stem cell technology know-how and now the Institute is making dreams come to reality of health improvement of human beings. For the first time in the World... * Developed cosmetic products by using secretion of embryonic stem cell originated for the first time in the world * Processing the development of stem cell originated yellow spot generation syndrome blindness medicine for the first time in the world(completion animal testing/requested for clinical demonstration). * Developed dedifferentiated stem cell by only using proteins for the first time in the world. * Developed differentiation induction technology of angioblast for the first time in the world. * Developed the production technology of artificial blood(red blood cell, blood platelet, immunocyte) from embryonic stem cell for the first time in the world. * Cooperation with spots medical conglomerates in US (Stem Cell Treatment) * Korean Government approves clinical test on stem cell study to CHA Medical Group.